In this joint report, Thomas J. Bollyky, CFR senior fellow for global health, economics, and development, and Amanda Glassman, director of global health policy at the Center for Global Development, propose applying Cash-on-Delivery (COD) Aid as a new incentive mechanism for tobacco control in low- and middle-income countries.
This report of the Working Group on Clinical Trials and Regulatory Pathways provides practical policy recommendations to help provide better, safer, and cheaper medicine and treatment to the 1 billion people suffering from neglected diseases.
There has been tremendous progress over the last decade in the development of health products for neglected diseases, but two substantial bottlenecks threaten our capacity to bring these products to those in need.
Visiting Fellow Tom Bollyky testified before the U.S. Senate Appropriations Subcommittee on Agriculture, Rural Development, the Food and Drug Administration, and Related Agencies on how the FDA can help develop programs for neglected diseases. Programs for neglected diseases, such as tuberculosis, malaria and other parasitic illnesses, lack a regulatory infrastructure to ensure programs work properly.
As the United Nations Framework Convention on Climate Change (UNFCCC) meeting convenes this month in Copenhagen, Denmark, intellectual property (IP) rights remain a highly contentious issue that threatens the long-term prospects of these negotiations. This note describes an approach that would facilitate the uptake of clean technologies, preserve incentives for privately financed innovation, and allow the Parties to address and move past the issue of IP rights in the UNFCCC negotiations.